AMAG
AMAG Articles
Amarin Corporation plc (NASDAQ: AMRN) is indicated up 50% at $5.35, well above the $3.85 52-week high, after its AMR101 met pivotal phase 3 study endpoints with highly statistically significant...
Published:
Last Updated:
This past week was filled with many surprises and earnings are still coming on strong. We wanted to look at some companies that either have unfinished business or are on deck with pending news...
Published:
Last Updated:
These are this Monday morning’s top early-bird analyst downgrades or cautious research calls from Wall Street firms: Advanced Micro Devices (AMD) Cut to Market Perform at FBR. Amicus Therapeutics...
Published:
Last Updated:
These are the top analyst upgrades, downgrades, and initiations seen from Wall Street early this Thursday morning: AMAG Pharmaceuticals (NASDAQ: AMAG) Cut to Hold at Citigroup. Apple Inc. (NASDAQ:...
Published:
Last Updated:
We have provided links through on our day trading alerts page this morning. Each stock is seeing active trading right before the open and brief explanations and analysis are offered at...
Published:
Last Updated:
These are the top analyst upgrades and positive research calls we have seen from Wall Street this Friday morning with about two hours until the market opens: Alcatel-Lucent (ALU) Raised to Outperform...
Published:
Last Updated:
Things are so bad at Crocs (CROX) that it is off nearly 50% down near $1. Optimer Pharmaceuticals (OPTR) continues to be volatility. Details here.. AgFeed (FEED) is getting crushed. NetApp (NTAP) is...
Published:
Last Updated:
These are some of the top pre-market analyst upgrades we are seeing this Wednesday morning: AMAG Pharmaceuticals (AMAG) Started as Overweight at JPMorgan Andersons (ANDE) Started as Outperform at...
Published:
AMAG Pharmaceuticals (NASDAQ: AMAG) has been added to the Nasdaq Biotechnology Index (NASDAQ: NBI) beginning May 19, 2008. AMAG shares up $1.26 at $39.85. The 52-week range is $38.16 to $72.95. Cell...
Published:
On tonight’s MAD MONEY on CNBC, Jim Cramer said he had a speculative biotech stock. His pick in the sector is AMAG Pharmaceuticals, Inc. (AMAG) because of its soon to be approved ferumoxytol, a...
Published:
Last Updated:
Below are some of the top issues affecting biotech shares today: AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company developing iron compounds to treat anemia, saw shares rise 4%...
Published: